Phase I clinical evaluation of bryostatin 1 in combination With 2-CdA [cladribine] in patients wth relapsed CLL [chronic lymphocytic leukaemia]
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Cladribine (Primary) ; Bryostatin-1
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 06 Sep 2005 New trial record.